Illumina

Illumina Beats In Q2, But Investment Thesis Remains Unclear

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Short Sellers Dump Amgen And Baxalta

Short Sellers Dump Vertex, Load Up On Baxalta

Short Sellers Dump Amgen And Baxalta

Short Sellers Dump Vertex, Load Up On Baxalta

Illumina Announces $100 Million Investment In Venture Fund To 'Improve Human Health By Unlocking The Power Of The Genome'

Barron's Picks And Pans: FedEx, Ilumina And More

Illumina Recent News

Mixed Earnings Expectations For Merck And Pfizer

Wild Short Interest Swings For These Three Biotech Stocks

Short Sellers Wary Of Biotech Stocks

Biotech Short-Sellers Prefer Amgen To Gilead Sciences

3 Biotech Stocks See Growing Short Interest

3 Biotech Stocks Bucking Short Interest Trends

Big Swings in Biotech Short Interest

Markets Marginally Lower In Quiet Trading Session

3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)

Surges In Biotech Short Interest (INCY, PCYC, REGN)

Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)

Market Wrap For March 5: Markets Calm Following Tuesday's Massive Rally

Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)

BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

Market Wrap For January 17: Stocks Finish Week With Mixed Results

Market Wrap For January 16: Markets End Two Day Winning Streak

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)

Biogen Idec, Pharmacyclics See Surges In Short Interest (BIIB, CELG, PCYC)

Gilead Sciences Leads In Rising Short Interest Among Biotechs